Compare Chart Industries Inc (GTLS) vs Recursion Pharmaceuticals Inc (RXRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Chart Industries Inc vs Recursion Pharmaceuticals Inc — how do they compare? Chart Industries Inc trades at $209.97 (market cap $10.05B), while Recursion Pharmaceuticals Inc trades at $3.2 (market cap $1.75B). The key difference: Chart Industries Inc is far larger — about 5.7× Recursion Pharmaceuticals Inc's market cap, and Chart Industries Inc is trading nearer its 52-week high, Recursion Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| GTLS | RXRX | |
|---|---|---|
Market Cap | $10.05B | $1.75B |
Sector | Technology | Health |
52-Week High | $209.91 | $6.79 |
52-Week Low | $167.29 | $2.84 |
Enterprise Value | $13.57B | $1.17B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Chart Industries Inc
Chart Industries is a leading manufacturer of highly engineered cryogenic equipment. Its products are used throughout the liquid gas supply chain, including clean energy applications like hydrogen and LNG.
Read more on GTLS →About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →
